VC Perspective on Longevity Biotech (LongBio): A Revolution in Medicine

​Join us for an exclusive session with Sebastian Brunemeier, one of the most influential figures at the intersection of biotechnology, ageing research, and venture capital.

​Sebastian A. Brunemeier is a biotech VC and company builder focused on longevity & regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital, and Partner at Long Game Ventures. Previously, he was Principal at Apollo Health Ventures, the largest longevity fund in the world, CIO and Co-Founder at Cambrian Biopharma, and Founder of Samsara Therapeutics. He was a DPhil (PhD) Clarendon Scholar in Biochemistry at the University of Oxford, a Fulbright Fellow, a Skaggs-Oxford Scholar at the Scripps Research Institute, and holds a dual MSc in Molecular Neuroscience and Biotech Business Management from University of Amsterdam.

​In this session, Sebastian will share insights on:

• ​The global longevity biotech investment landscape

• ​What makes a longevity startup investor-ready

• ​The intersection of science, entrepreneurship, and capital

• ​Career pathways for students and researchers in the field

• ​His own journey from academic ageing research to founding and funding frontier biotech ventures

​Open to all students, faculty, researchers, and future founders interested in biotech, aging science, and healthspan innovation.

​Event Highlights:

• ​Deep dive into the world of longevity investing and emerging biotech

• ​Learn what makes a longevity startup investor-ready

• ​Breathtaking view of London from the 32nd floor venue

• ​Complimentary Longevity Protein Shake Samples to fuel your healthspan journey

​Free registration – limited seats available. Reserve yours now!

​ https://www.linkedin.com/in/sebastianlongbio/

​#LongevityVC #HealthyAgeing #Oxfordsoceityforageingandlongevity #OSAL #BiotechInnovation #SebastianBrunemeier